Geron Corporation (GERN): President and CEO John A. Scarlett Bought 50,000 Shares
GERON OWNS MOST OF THE KEY STEM CELL PATENTS THAT EXIST. THEY ARE THE WORLDS LEADING STEM CELL BIOTECH COMPANY, AND ANYONE WHO KNOWS HOW ALL GREAT BIOTECH COMPANIES GET STARTED KNOWS THAT THEY OPERATE WITH DEFICITS UNTIL THEIR FIRST PRODUCT GETS TO MARKET. COMPANIES LIKE AMGEN, GILEAD, DANDREON, ETC ALL BEGAN SAME AS GERON. YOU ARE OBVIOUSLY AND SADLY IGNORANT OF THE PROCESS, AND CHOOSE TO ATTACK THE LEADING COMPANY OF WHAT IS FAST BECOMING THE WORLD'S FUTUIRE IN HEALTHCARE SCIENCE, STEM CELLS.
President and CEO of Geron Corporation (GERN) John A. Scarlett bought 50,000 shares on April 1, 2013 at an average price of $1.10. Geron Corporation was incorporated in Delaware on Nov. 28, 1990. Geron Corporation has a market cap of $143.632 million; its shares were traded at around $1.10.
Geron Corp. recently reported its fourth quarter 2012 financial results. Net loss for the fourth quarter of 2012 was $15.9 million or $0.12 per share, compared to $31.9 million or $0.25 per share, for the comparable 2011 period.
Jean-Marie Eveillard owns 1,760,934 shares as of Dec. 31, 2012, which accounts for 0.0088% of the $28.07 billion portfolio of First Eagle Investment Management, LLC.
Senior Vice President Alliance and Program Management Melissa Kelly Behrs sold 28,292 shares of GERN stock on Jan.17, 2013 at the average price of $1.65. The price of the stock has decreased by 33.33% since.
GERON OWNS MOST OF THE KEY STEM CELL PATENTS THAT EXIST. THEY ARE THE WORLDS LEADING STEM CELL BIOTECH COMPANY, AND ANYONE WHO KNOWS HOW ALL GREAT BIOTECH COMPANIES GET STARTED KNOWS THAT THEY OPERATE WITH DEFICITS UNTIL THEIR FIRST PRODUCT GETS TO MARKET. COMPANIES LIKE AMGEN, GILEAD, DANDREON, ETC ALL BEGAN SAME AS GERON. YOU ARE OBVIOUSLY AND SADLY IGNORANT OF THE PROCESS, AND CHOOSE TO ATTACK THE LEADING COMPANY OF WHAT IS FAST BECOMING THE WORLD'S FUTUIRE IN HEALTHCARE SCIENCE, STEM CELLS.
President and CEO of Geron Corporation (GERN) John A. Scarlett bought 50,000 shares on April 1, 2013 at an average price of $1.10. Geron Corporation was incorporated in Delaware on Nov. 28, 1990. Geron Corporation has a market cap of $143.632 million; its shares were traded at around $1.10.
Geron Corp. recently reported its fourth quarter 2012 financial results. Net loss for the fourth quarter of 2012 was $15.9 million or $0.12 per share, compared to $31.9 million or $0.25 per share, for the comparable 2011 period.
Jean-Marie Eveillard owns 1,760,934 shares as of Dec. 31, 2012, which accounts for 0.0088% of the $28.07 billion portfolio of First Eagle Investment Management, LLC.
Senior Vice President Alliance and Program Management Melissa Kelly Behrs sold 28,292 shares of GERN stock on Jan.17, 2013 at the average price of $1.65. The price of the stock has decreased by 33.33% since.
No comments:
Post a Comment